Filing Flows › Serina Therapeutics (SER) › Q2 2025 › vs Q2 2024
Serina Therapeutics (SER) Q2 2025 vs Q2 2024 (year over year)
Serina Therapeutics's revenue rose $79K (+155%) from $51K in Q2 2024 to $130K in Q2 2025.
Serina Therapeutics, Q2 2025: revenue $130K (+155% year over year), net loss $6.5M, operating cash flow −$3.8M. The chart draws each line against Q2 2024, the increases inside each band.
Every line
| Line | Q2 2025 | Q2 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $130K | $51K | $79K | +155% |
| Net loss | $6.5M | −$5.2M | $11.6M | — |
| Costs & expenses | $6.6M | $9.1M | −$2.5M | -28% |
| Operating costs | $5.7M | $3.9M | $1.8M | +45% |
| Interest & other, net | $897K | −$9.0M | $9.9M | — |
| Research & development | $3.2M | $1.6M | $1.6M | +98% |
| General & admin | $2.5M | $2.3M | $220K | +9% |
| Operating cash sources | $6.5M | −$5.2M | $11.6M | — |
| Depreciation & amortization | $16K | $57K | −$41K | -72% |
| Share-based compensation | $890K | $458K | $432K | +94% |
| Working capital & other | $1.8M | −$13.7M | $15.5M | — |
| Cash used in operations | $3.8M | $8.0M | −$4.3M | -53% |
| Net loss absorbed | $6.5M | −$5.2M | $11.6M | — |
Questions
How much did Serina Therapeutics's revenue grow year over year in Q2 2025?
Serina Therapeutics's revenue rose $79K (+155%) from $51K in Q2 2024 to $130K in Q2 2025.